Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)
Clinical trial NCT06160492 · RECRUITING
Trial details
- NCT number
- NCT06160492
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2026-02-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.